乌克兰的干细胞治疗

Director, GCP

Responsibilities The Director, GCP will be required to oversee all and participate in, quality assurance auditing of all activities subject to the, “ICH Good Clinical/Laboratory Practice: 综合指南,” (GCP/GLP’s), 支持质量保证计划 (质量保证) to ensure that Allergan project data and summary statements are of known and documented 阅读更多…

乌克兰的干细胞治疗

Clinical Research Associate/Clinical Research Coordinator

Responsibilities The CRA/CRC is responsible for the monitoring or auditing of all activities subject to the, “ICH 良好临床实践: 综合指南,” (地面控制点), supporting client programs administrated by Watermark ensure project data and summary statements are of known and documented quality. Requirements Will be expected to travel extensively to study 阅读更多…

乌克兰的干细胞治疗

CRA certification

A Clinical Research Associate (加拿大税务局) is a profession defined by Good clinical practice guidelines (ICH GCP). The main function of a clinical research associate is to monitor clinical trials. He or she may work directly with the sponsor company of a clinical trial, as an independent freelancer or for a Contract Research Organization (合同研究组织). A 阅读更多…

Regenerative Therapy for Liver Cirrhosis Based on Intrahepatic Arterial Infusion of Autologous Subcutaneous Adipose Tissue-Derived Regenerative (Stem) Cells: Protocol for a Confirmatory Multicenter Uncontrolled Clinical Trial

AbstractBackground:Liver cirrhosis results from chronic hepatitis, and is characterized by advanced fibrosis due to long-term hepatic inflammation. Cirrhosis ultimately leads to manifestations of jaundice, ascites, and encephalopathy, and increases the risk of hepatocellular carcinoma. Once cirrhosis is established, resulting in hepatic failure, no effective treatment is available. 所以, novel therapies 阅读更多…

Mesenchymal stem cell therapy for liver disease: current status and future perspectives

Abstract Purpose of review Liver transplantation is the gold standard for the treatment of end-stage liver disease. 然而, a shortage of donor organs, high cost, and surgical complications limit the use of this treatment. Cellular therapies using hepatocytes, hematopoietic stem cells, bone marrow mononuclear cells, and mesenchymal stem cells (间充质干细胞) 阅读更多…

The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues

Mesenchymal stem cell (MSC) transplantation is a novel treatment for liver diseases due to the roles of MSCs in regeneration, fibrosis inhibition and immune regulation. 然而, the mechanisms are still not completely understood. Despite the significant efficacy of MSC therapy in animal models and preliminary clinical trials, issues remain. 这 阅读更多…

Effect of mesenchymal stem cell in liver regeneration and clinical applications

AbstractLiver disease accounts for approximately 2 million deaths per year worldwide with cirrhosis, viral hepatitis, and malignancy being the most common causes. Consequently, the regenerative capacity of the liver is a topic of extreme interest in the search for curative therapies to end-stage liver disease. 间充质干细胞 (间充质干细胞) 有 阅读更多…

Adult Stem Cell Therapy in Liver Cirrhosis Management: Current Practices and Future Perspectives

AbstractLiver cirrhosis is a leading cause of mortality worldwide. Although treatable by liver transplantation, quality of life is unlikely to drop in all the patients after five years. The shortage of matching donors and the high risk of surgical-associated complications further limits the therapeutic potential of transplantation. Since adult stem 阅读更多…

Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis

AbstractLiver cirrhosis is a major cause of mortality and a common end of various progressive liver diseases. Since the effective treatment is currently limited to liver transplantation, stem cell-based therapy as an alternative has attracted interest due to promising results from preclinical and clinical studies. 然而, there is still much 阅读更多…

Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells

AbstractBackground & aims: Liver transplantation is the primary treatment for various end-stage hepatic diseases but is hindered by the lack of donor organs and by complications associated with rejection and immunosuppression. There is increasing evidence to suggest the bone marrow is a transplantable source of hepatic progenitors. We previously reported 阅读更多…

Could Stem Cell Therapy be the Cure in Liver Cirrhosis?

AbstractOver the past five decades, liver cirrhosis has become an increasingly prevalent disease and one that will often require considerable medical intervention. 然而, current treatment options have demonstrated severe problems that have prompted research to provide a suitable alternative. These treatments are scarcely available, very expensive and present at a 阅读更多…

Mesenchymal stem cell therapy for liver disease: full of chances and challenges

AbstractLiver disease is a major health problem that endangers human health worldwide. 现在, whole organ allograft transplantation is the gold standard for the treatment of end-stage liver disease. A shortage of suitable organs, high costs and surgical complications limit the application of liver transplantation. Mesenchymal stem cell therapy has been 阅读更多…

Лечение Модитен- Депо

При прохождении лечения Модитен Депо нужно соблюдать осторожность. В первые дни ничего не происходит. Затем на 3 – 5 день наступает момент ощущения действия препарата. Это может быть сонливость, ощущение притупленности умственных реакций. На 6-10 дни может наблюдаться акатизиято есть непроизвольные движения ногами или руками. Может и ничего 阅读更多…

Clinical Trial Management System training

Schedule: Getting Started Study2.1 New Study Setup2.2 Study SetupSubject Visit Schedule2.3 Study SetupMonitoring and Subject Settings2.5 Study SetupContract Templates2.7 Milestones & Tasks2.8 Study Dashboard Visit Reports3.1 Defining eVisit Reports3.2 eVisit Report Authoring & Approval3.3 eVisit Report & Monitoring Enhancements Documents4.1 Document Management Overview4.2 Site 阅读更多…

干细胞疗法